Background Cirrhosis is the outcome of chronic liver disease of any etiology due to
progressive liver injury and fibrosis. Consequently, cirrhosis leads to portal hypertension …

METHODS: We conducted a systematic review and meta-analysis of the prevalence of
sarcopenia in LC. The literature was screened through 6 electronic databases from the …

BACKGROUND Progressive malnutrition coexists with liver diseases, particularly in patients
with cirrhosis. Early diagnosis of malnutrition in patients with advanced stages of chronic …

Methods: Live liver donors (LLDs) who were fit with no or minimal steatosis were
randomized to receive either a customized low-calorie diet with calorie intake equalling their …

Background & aims There is no “gold standard” tool for the assessment of frailty in cirrhosis.
This study compares Liver Frailty Index (LFI), Short Physical Performance Battery (SPPB) …

Background Sarcopenia is associated with poor outcomes in patients with cirrhosis.
However, the prevalence of and associated factors for developing sarcopenia in this …

Background: Sarcopenia is strongly associated with poor outcome in cirrhosis. There are
little prospective data that sarcopenia influences outcomes in critically ill cirrhotics (CICs) …

Background Skeletal muscle index (SMI), the gold standard for sarcopenia, cannot measure
muscle strength and requires specialized software and training. Hand-grip strength (HGS) …

Sarcopenia, which is characterized by decline in muscle mass, muscle strength, and
physical performance, is common in patients with chronic liver disease (CLD) and is …

Methods We performed a search in Medline, Embase and Cochrane Central. Of the 12276
references initially recovered, 34 were included. Results Frailty and sarcopenia presented a …